A new research presented at UEG(United European Gastroenterology) week 2019 Barcelona has shown that resistance to antibiotics(Clarithromycin, levofloxacin) commonly used to treat H.Pylori infections has more than doubled in the last 20 years (1998-2018).
BARCELONA: Resistance to commonly-used antibiotics for treating harmful bacteria related to a variety of stomach conditions has more than doubled in 20 years, new research presented today at UEG Week Barcelona 2019 has shown.
“The findings of this study are certainly concerning, as H. pylori is the main cause of peptic disease and gastric cancer,” commented Mário Dinis-Ribeiro, President of the European Society of Gastrointestinal Endoscopy. “The increasing resistance of H. pylori to a number of commonly-used antibiotics may jeopardize prevention strategies.”
The rate of ‘primary’ clarithromycin resistance in H. pylori in Europe in 2018 (%) found in the study was: